Literature DB >> 16695791

EVALUATION OF THERAPEUTIC SUBSTANCES EMPLOYED FOR THE RELIEF OF BRONCHOSPASM. VI. AMINOPHYLLINE.

M S Segal1, L Levinson, E Bresnick, J F Beakey.   

Abstract

Entities:  

Year:  1949        PMID： 16695791      PMCID： PMC439676          DOI： 10.1172/JCI102153

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  3 in total

1.  THE ACTION OF HISTAMINE ON THE RESPIRATORY TRACT IN NORMAL AND ASTHMATIC SUBJECTS.

Authors:  J J Curry
Journal:  J Clin Invest       Date:  1946-11       Impact factor: 14.808

2.  EVALUATION OF THERAPEUTIC SUBSTANCES EMPLOYED FOR THE RELIEF OF BRONCHOSPASM. V. ADRENERGIC AGENTS.

Authors:  E Bresnick; J F Beakey; L Levinson; M S Segal
Journal:  J Clin Invest       Date:  1949-09       Impact factor: 14.808

3.  COMPARATIVE ACTION OF ACETYL-BETA-METHYL CHOLINE AND HISTAMINE ON THE RESPIRATORY TRACT IN NORMALS, PATIENTS WITH HAY FEVER, AND SUBJECTS WITH BRONCHIAL ASTHMA.

Authors:  J J Curry
Journal:  J Clin Invest       Date:  1947-05       Impact factor: 14.808
  3 in total
  5 in total

1.  Study of theophylline plasma levels after oral administration of new theophylline compounds.

Authors:  M TURNER-WARWICK
Journal:  Br Med J       Date:  1957-07-13

Review 2.  Clinical pharmacokinetics of theophylline.

Authors:  R I Ogilvie
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

3.  Comparative effect of epinephrine and aminophylline in the treatment of asthma.

Authors:  D Appel; C Shim
Journal:  Lung       Date:  1981       Impact factor: 2.584

4.  The use of aminophylline by inhalation.

Authors:  P J Thompson; M W Kemp; W McAllister; M Turner-Warwick
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

5.  Aminophylline suppresses stress-induced visceral hypersensitivity and defecation in irritable bowel syndrome.

Authors:  Teita Asano; Ken-Ichiro Tanaka; Arisa Tada; Hikaru Shimamura; Rikako Tanaka; Hiroki Maruoka; Mitsuko Takenaga; Tohru Mizushima
Journal:  Sci Rep       Date:  2017-01-05       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.